TTNP Titan Pharmaceuticals, Inc. Stock Quote

TTNP [NASD]

Index	-	P/E	-	EPS (ttm)	-1.96	Insider Own	7.00%	Shs Outstand	9.86M	Perf Week	-12.98%
Market Cap	22.50M	Forward P/E	-	EPS next Y	-1.96	Insider Trans	0.00%	Shs Float	8.49M	Perf Month	-26.21%
Income	-7.40M	PEG	-	EPS next Q	-0.96	Inst Own	3.70%	Short Float	17.61%	Perf Quarter	-28.08%
Sales	4.80M	P/S	4.69	EPS this Y	79.90%	Inst Trans	60.04%	Short Ratio	0.95	Perf Half Y	-46.89%
Book/sh	0.94	P/B	2.43	EPS next Y	44.20%	ROA	-186.50%	Target Price	-	Perf Year	-68.66%
Cash/sh	0.55	P/C	4.17	EPS next 5Y	-	ROE	-770.40%	52W Range	2.15 - 14.06	Perf YTD	-30.70%
Dividend	-	P/FCF	-	EPS past 5Y	54.60%	ROI	-181.30%	52W High	-83.87%	Beta	0.77
Dividend %	-	Quick Ratio	1.70	Sales past 5Y	23.70%	Gross Margin	90.20%	52W Low	5.49%	ATR	0.19
Employees	12	Current Ratio	1.70	Sales Q/Q	84.60%	Oper. Margin	-	RSI (14)	29.04	Volatility	7.56% 6.56%
Optionable	Yes	Debt/Eq	0.17	EPS Q/Q	79.90%	Profit Margin	-	Rel Volume	0.08	Prev Close	2.28
Shortable	Yes	LT Debt/Eq	0.09	Earnings	-	Payout	-	Avg Volume	1.57M	Price	2.27
Recom	2.00	SMA20	-16.59%	SMA50	-28.03%	SMA200	-53.30%	Volume	12,132	Change	-0.53%

Jun-26-19

Initiated

Maxim Group

Buy

Nov-10-17

Downgrade

ROTH Capital

Buy → Neutral

Mar-31-21 04:30PM	Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K PR Newswire
Feb-01-21 07:30AM	Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program PR Newswire +9.81%
Jan-15-21 09:15AM	Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering PR Newswire -9.43%
Dec-16-20 08:00AM	Titan Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements PR Newswire -6.05%
Dec-01-20 04:56AM	TTNP: Coverage Discontinued Zacks Small Cap Research -26.27%
Nov-30-20 12:50PM	Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire
Nov-16-20 08:45AM	Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire
Nov-02-20 08:00AM	Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT Pharma's Kappa Opioid Agonist Peptide, JT-09 PR Newswire -22.31%
Oct-30-20 08:14AM	7 Penny Stocks to Watch in November InvestorPlace
Oct-28-20 03:00PM	Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering PR Newswire +29.88%
08:00AM	Titan Pharmaceuticals Enters Into Definitive Agreement To Acquire JT Pharma's Kappa Opioid Agonist Peptide, JT-09 PR Newswire
Oct-26-20 06:30AM	Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon PR Newswire +9.11%
Oct-15-20 08:00AM	Titan Pharmaceuticals Provides a Strategic & Corporate Update PR Newswire -7.20%
Sep-24-20 09:00AM	Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct Offering PR Newswire -12.66%
Sep-18-20 04:45PM	Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation PR Newswire
Sep-16-20 01:05PM	Here's What We Think About Titan Pharmaceuticals' (NASDAQ:TTNP) CEO Pay Simply Wall St.
Sep-15-20 08:30AM	Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare PR Newswire +16.47%
Sep-14-20 08:30AM	Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation PR Newswire -8.43%
Aug-26-20 05:45AM	TTNP: Indegene to Advance Probuphine Commercialization Zacks Small Cap Research
Aug-14-20 08:45AM	Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results PR Newswire -5.76%
Aug-10-20 04:30PM	Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020 PR Newswire
Jul-08-20 08:00AM	Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation PR Newswire
Jun-24-20 08:00AM	Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership PR Newswire +24.03%
Jun-16-20 08:00AM	Titan Pharmaceuticals Launches Virtual REMS Training For Probuphine Health Care Providers PR Newswire
Jun-01-20 05:20AM	TTNP: First Quarter 2020 Financial and Operational Results Zacks Small Cap Research
May-15-20 08:45AM	Titan Pharmaceuticals Reports First Quarter 2020 Financial Results PR Newswire -19.14%
May-11-20 04:03PM	Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020 PR Newswire
Apr-09-20 06:15AM	TTNP: Full Year 2019 Financial and Operational Results Zacks Small Cap Research
Apr-02-20 09:47PM	Edited Transcript of TTNP earnings conference call or presentation 30-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Mar-31-20 12:43PM	Penny Stocks to Buy Using Technical Analysis for April 2020 Investopedia -14.65%
Mar-30-20 04:03PM	Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results PR Newswire +9.20%
02:30PM	Titan Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-26-20 08:00AM	Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020 PR Newswire
Mar-05-20 09:00AM	Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants PR Newswire +12.57%
Feb-18-20 08:55AM	Did Changing Sentiment Drive Titan Pharmaceuticals's (NASDAQ:TTNP) Share Price Down A Disastrous 99%? Simply Wall St.
Jan-13-20 08:00AM	Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule PR Newswire
Jan-07-20 09:15AM	Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering PR Newswire -19.83%
Dec-30-19 08:00AM	Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors PR Newswire +22.72%
Dec-17-19 10:30AM	Should You Worry About Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) CEO Pay? Simply Wall St.
Dec-04-19 01:22PM	Edited Transcript of TTNP earnings conference call or presentation 14-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-03-19 09:00AM	Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference PR Newswire +20.43%
Nov-25-19 05:15AM	TTNP: Waiting for Revenue Turn Zacks Small Cap Research
Nov-14-19 04:03PM	Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results PR Newswire +12.04%
Nov-07-19 04:30PM	Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire
Oct-22-19 08:00AM	Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics PR Newswire
Oct-18-19 10:23AM	These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals +5.11%
Oct-16-19 09:20AM	Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering PR Newswire -51.02%
Oct-01-19 08:00AM	Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities PR Newswire
Sep-18-19 08:00AM	Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant PR Newswire +20.91%
Aug-30-19 08:01PM	Edited Transcript of TTNP earnings conference call or presentation 14-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-19 11:30AM	TTNP: Long on Opportunity, Short on Capital Zacks Small Cap Research -6.17%
Aug-17-19 09:59AM	Some Titan Pharmaceuticals (NASDAQ:TTNP) Shareholders Have Copped A 99% Share Price Wipe Out Simply Wall St.
Aug-16-19 07:33AM	The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission Benzinga +7.51%
Aug-14-19 04:03PM	Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire
07:32AM	Q2 Earnings Preview For Titan Pharmaceuticals Benzinga
Aug-09-19 05:00PM	Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow PR Newswire
Aug-07-19 09:15AM	Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering PR Newswire -27.38%
Jul-09-19 09:00AM	Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark PR Newswire
Jul-03-19 10:54AM	What Does Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) Balance Sheet Tell Us About It? Simply Wall St.
Jun-26-19 09:10AM	Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine PR Newswire -5.56%
Jun-04-19 07:00AM	Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine® PR Newswire +11.61%
May-29-19 02:15PM	TTNP: A+ Partnerships: AllianceRx, AppianRx & Accredo Zacks Small Cap Research
May-23-19 08:10AM	Edited Transcript of TTNP earnings conference call or presentation 15-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-15-19 04:08PM	Titan Pharmaceuticals: 1Q Earnings Snapshot Associated Press
04:03PM	Titan Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire
May-13-19 07:00AM	Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo® PR Newswire
May-08-19 08:00PM	Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow PR Newswire
May-06-19 03:12PM	Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-29-19 07:00AM	Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine® PR Newswire
Apr-12-19 05:00PM	Knight Therapeutics: Use of PROBUPHINE for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast GlobeNewswire
Apr-11-19 09:45AM	TTNP: EMA Approval of Probuphine Expected 2Q:19 Zacks Small Cap Research
Apr-02-19 01:06AM	/C O R R E C T I O N -- Titan Pharmaceuticals, Inc./ PR Newswire
Apr-01-19 05:07PM	Titan Pharmaceuticals: 4Q Earnings Snapshot Associated Press
04:30PM	Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire
Mar-28-19 07:00AM	Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services PR Newswire
Mar-26-19 07:00AM	Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019 PR Newswire
Feb-25-19 02:20PM	4 Healthcare Stocks Looking To Kick Off A Strong Week ACCESSWIRE +27.78%
07:00AM	Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine® PR Newswire
Feb-08-19 09:30AM	TTNP: Shipments Spike in 2H:18 Zacks Small Cap Research
Feb-01-19 02:31PM	4 Healthcare Stocks Looking To Start February Off Strong ACCESSWIRE +34.15%
12:01PM	How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares? Simply Wall St.
11:46AM	Why Titan Pharmaceuticals Stock Is Skyrocketing Today InvestorPlace
11:10AM	Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc. ACCESSWIRE
Jan-31-19 06:36PM	Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch PR Newswire
Jan-24-19 07:00AM	Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire
Dec-21-18 12:54PM	Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT Thomson Reuters StreetEvents -8.56%
Dec-10-18 10:35AM	Alternatives to Watch ACCESSWIRE
Nov-21-18 07:25AM	Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Nov-20-18 11:15AM	TTNP: New CCO Implementing Targeted Strategy Zacks Small Cap Research
Nov-14-18 04:38PM	Titan Pharmaceuticals: 3Q Earnings Snapshot Associated Press +10.23%
04:01PM	Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results PR Newswire
Nov-08-18 07:00AM	Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 09:30AM	Biotech Stocks and the Midterm Elections ACCESSWIRE
Nov-05-18 08:55AM	3 Stocks To Watch As Healthcare Market Evolves ACCESSWIRE +18.74%
07:00AM	Todays Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Titan Pharmaceuticals ACCESSWIRE
Nov-02-18 10:30AM	Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday ACCESSWIRE +22.62%
Oct-30-18 09:45AM	3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE -5.92%
Oct-29-18 08:00AM	Knight Therapeutics Announces the Canadian launch of PROBUPHINE for Opioid Use Disorder GlobeNewswire
Oct-23-18 02:40PM	These 3 Stocks Are Moving Higher This Month ACCESSWIRE +36.36%
Oct-22-18 08:00AM	Today's Research Reports on Trending Tickers: Titan Pharmaceuticals and Amarin Corporation ACCESSWIRE -6.98%

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience